期刊文献+

褪黑素对帕金森病模型大鼠代谢机能和DA能神经元的保护作用 被引量:4

The protective effect of melatonin on dopaminergic neurons and on the metabolic function in rats with Parkinson disease
下载PDF
导出
摘要 目的我们前期研究证实6-羟基多巴胺(6-OHDA)明显诱导性帕金森病(PD)模型大鼠行为学障碍及其纹状体神经元的损伤。目前进一步借助褪黑素(MT)探查证实6-羟基多巴胺对PD模型大鼠纹状体代谢机能损害和黑质DA能神经元的保护作用。方法选取55只成年雄性SD大鼠,并随机分成正常对照组(包括正常对照和稀释剂对照)、6-OHDA处理组和6-OHDA+MT处理组,实验借助Micro PET-CT、免疫组织化学染色及Westernblot技术检测和比较实验大鼠纹状体代谢、TH阳性纤维密度及TH蛋白表达量的变化。所获得数据使用SPSS20.0统计学软件进行分析处理,P<0.05为有统计学意义。结果 Micro PET-CT检测结果显示,6-OHDA组大鼠纹状体糖代谢机能(1.34±0.114)明显较对照组(4.36±0.114)低(P=0.00),而6-OHDA+MT处理组(4.14±0.114)与6-OHDA组相比糖代谢机能增高,差异也具有统计学意义(P=0.00)。纹状体内TH阳性纤维密度和TH蛋白表达水平在6-OHDA组(分别为0.324±0.018、0.434±0.338)均显著低于对照组(0.378±0.026、1.626±0.526)(P=0.00,P=0.00)和6-OHDA+MT处理组(0.37±0.010、1.136±0.494)(P=0.00,P=0.03),但对照组和6-OHDA+MT处理组之间差异无统计学意义(P=0.52,P=0.12)。结论褪黑素对PD模型大鼠纹状体代谢机能障碍和中脑黑质DA能神经元损伤具有一定的保护作用。 Objective Our previous studies showed that 6-hydroxydopamine (6-OHDA) evidently induced behavioral disor- ders and damage of striatal neurons in rats with Parkinson' s disease. Further study was conducted to explore the effects of melatonin on dopaminergic nerve cells and on the metabolic function in rats with Parkinson' s disease induced by 6-hydroxydopamine. Meth- ods 55 male adult SD rats were randomly divided into three groups : control group, 6-OHDA group and 6-OHDA+MT group. Micro PET-CT, immunohistochemistry technique and Western-blot was used to detect the changes ofglycometabolism, density of TH immunoreactive fibers and TH protein expression. The data were analyzed with SPSS. Results Micro PET-CT revealed that, compared to control group(4.36±0.114) and 6-OHDA+MT group(4.14±0.114), 6-OHDA group( 1.34±0.114)significantly had glycometabolism hypofunction (P=0.00, P=0.00), control group and 6-OHDA + MT group showed no significantly difference (P=0.10). In addition, there is a significant reduction in TH immunoreactive fibers and TH protein expression for 6-OHDA group (0.324±0.018, 0.434±0.338 respectively), compared with control group 0.378±0.026, 1.626±0.526)(P=0.00, P=0.00)and 6-OHDA+MT (0.37±0.010, 1.136±0.494)(P=0.00, P=0.03) , control group and 6-OHDA + MT group showed no significantly difference (P--0.52,P= 0.12) .Conclusion Melatonin could protect metabolic function of rats and prevent the damage of dopaminergic nerve fibers.
出处 《解剖学研究》 CAS 2017年第2期81-84,F0003,F0004,共6页 Anatomy Research
基金 国家自然科学基金(No.81471288 No.31070941) 湖南省教育厅项目(16C1317)
关键词 帕金森病 糖代谢 褪黑素 6-羟基多巴胺 PET-CT Parkinson disease Glycometabolism Melatonin 6-hydroxydopamine PET-CT
  • 相关文献

参考文献2

二级参考文献25

  • 1Samii A, Nutt JG, Ransom BR. Parkinson' s disease. The Lancet,2004 , 363 (9423) : 1783-1793.
  • 2Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian and Shanghai. Lancet, 2005 ; 365(9459) :595-597.
  • 3Eslamboli A. Marmoset monkey model of Parkinson's disease: which model, when and why? Brain Res Bull, 2005;68(3) : 140- 149.
  • 4Snow NA, Vingerb-oets FJ, Langston JW, et al. Pattern of dopaminergie loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatry,2000;68 (3) :313-316.
  • 5王雁.帕金森病的病理模型.见:吴俊芳,刘态主编.现代神经科学研究方法.北京:中国协和医科大学出版社,2006:941-942.
  • 6Nagai Y, Obayashi S, Ando K, et al. Progressive changes of pre- and post-synaptic dopaminergic biomarkers in conscious MPTP-treated cynomolgus monkeys measured by positron emission tomography. Synapse, 2007 ; 61 (10) : 809-819.
  • 7Chen MK, Kuwabara H, Zhou Y, et al. VMAT2 and dopamine neuron loss in a primate model of Parkinson ,s disease. J Neurochem, 2008 ; 105 (1) : 78-90.
  • 8Oiwa Y, Eberling JL, Nagy D, et al. Overlesioned hemiparkinsonian non human primate modelz correlation between clinical, neurochemical and histochemical changes. Front Biosci, 2003 , 8, al 55-a166.
  • 9Brownell AL, Canales K, Chen YI, et al. Mapping of brain ruction after MPTP-induced neurotoxicity in a primate Parkinson' s disease model. Neuroimage, 2003, 20 (2) : 1064- 1075.
  • 10Baudrexel S, Witte T, Seifried C, et al. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Pa,:kinson's disease. Neuroimage,2011;55(4) :1728-1738.

共引文献7

同被引文献34

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部